BONUSCAP-ZERTIFIKAT - BIONTECH ADR Share Price

Certificat

DE000HD4AL96

Market Closed - BOERSE MUENCHEN 20:46:34 17/05/2024 BST
110.6 EUR -4.83% Intraday chart for BONUSCAP-ZERTIFIKAT - BIONTECH ADR
Current month+7.52%
1 month+16.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/05/24 110.6 -4.83%
16/05/24 116.2 +1.56%
15/05/24 114.4 +0.86%
14/05/24 113.4 -1.78%
13/05/24 115.5 +2.05%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 08:46 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer UniCredit UniCredit
WKN HD4AL9
ISINDE000HD4AL96
Date issued 02/04/2024
Strike 170 $
Maturity 20/12/2024 (216 Days)
Parity 1 : 1
Emission price 109.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 118.5
Lowest since issue 91.13
Spread 0.07
Spread %0.06%

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
83.34 EUR
Average target price
105.4 EUR
Spread / Average Target
+26.45%
Consensus